An oligopeptide/aptamer-conjugated dendrimer-based nanocarrier for dual-targeting delivery to bone

M Ren, Y Li, H Zhang, L Li, P He, P Ji… - Journal of Materials …, 2021 - pubs.rsc.org
Bone targeting is one of the most potentially valuable therapeutic methods for medically
treating bone diseases, such as osteoarthritis, osteoporosis, nonunion bone defects, bone …
被引用次数：28 相关文章

An oligopeptide/aptamer-conjugated dendrimer-based nanocarrier for dual-targeting delivery to bone

M Ren, Y Li, H Zhang, L Li, P He… - Journal of materials …, 2021 - pubmed.ncbi.nlm.nih.gov
Bone targeting is one of the most potentially valuable therapeutic methods for medically
treating bone diseases, such as osteoarthritis, osteoporosis, nonunion bone defects, bone …

An oligopeptide/aptamer-conjugated dendrimer-based nanocarrier for dual-targeting delivery to bone.

M Ren, Y Li, H Zhang, L Li, P He, P Ji… - Journal of Materials …, 2021 - europepmc.org
Bone targeting is one of the most potentially valuable therapeutic methods for medically
treating bone diseases, such as osteoarthritis, osteoporosis, nonunion bone defects, bone …

[引用][C] An oligopeptide/aptamer-conjugated dendrimer-based nanocarrier for dual-targeting delivery to bone

M Ren, Y Li, H Zhang, L Li, P He, P Ji, S Yang - 2021